The TÜV SÜD EC-Type Examination Certificate granted to Embotech for its Autonomous Tractor Solution and CE marking confirm the system is approved for autonomous operations in industrial logistics.

Swiss privacy-focused company Threema has transferred ownership to the Germany-based firm Comitis Capital GmbH. Since 2020, the company had been under the leadership of private equity firm Afinum ...

Since the release of its Version 1.0 platform, Copresence has seen over 30,000 avatars created by indie developers and 3D artists. The company has now partnered with multiple AAA gaming studios to ...

Last year Switzerland regained access to Horizon Europe’s European Innovation Council ( EIC) programmes. Euresearch, the Swiss network for European research and innovation funding, has announced this ...

Oculis, Legacy Healthcare and Neurosterix are advancing their drug pipelines with major clinical milestones. Oculis’ Privosegtor received breakthrough therapy designation from the U.S. Food and Drug ...

The Fribourg-based sportswear startup Revario has just hit CHF 1 million in sales. This achievement is even more remarkable given that the company, founded by Michael Ingram, has so far sold its ...

Founded as a spin-out from ams OSRAM’s corporate incubator, EPFL Innovation Park based AlphaLum combines industrial optics heritage with a team experienced in scaling innovative photonic technologies.

Seven financing rounds, one carve-out, one strategic investment and four sales: Swiss founders are taking different paths to growth.

Ahead Health, the Zurich-based preventive healthcare company providing an AI-powered platform to democratise access to sophisticated preventative healthcare, has finalized its seed funding round, ...

The Watt d’Or Energy prize held by the Swiss Federal Office of Energy was established in 2007 to showcase exceptional products or services in the energy sector and to motivate the private sector, ...

DistalMotion, the Lausanne-based company empowering access to robotic surgery in outpatient sites of care, has secured a strategic investment from Johnson & Johnson, through its corporate venture ...

Swiss Agency for Therapeutic Products (Swissmedic), has approved Santhera Pharmaceuticals’ drug candidate AGAMREE® (vamorolone) for the treatment of Duchenne muscular dystrophy (DMD) in patients four ...